FIELD: biotechnologies.
SUBSTANCE: method includes the human blood test by the method of polimerase chain reaction with hybridisation-fluorescent detection of products of amplification. The circulating levels of microRNA are determined with simultaneous determination of concentration of microRNA-423-5r more than 35500 copies/mcl and mikroRNA-34a-5r more than 4538 copies/mcl establish chronic heart failure, and at simultaneous determination of concentration mikrornk-423-5r above 35500 copies/mcl and the concentration of microRNA-21-5r above 711755 copies/mcl the chronic heart failure against the background of inflammatory cardiomyopathy is identified.
EFFECT: invention allows to diagnose with high reliability the chronic heart failure at early stages of the disease.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSTICS OF CHRONIC HEART FAILURE BY USING CIRCULATING LEVELS OF MICRORNA | 2014 |
|
RU2569458C1 |
| METHOD FOR DETERMINING ETIOLOGY OF CHRONIC HEART FAILURE | 2020 |
|
RU2748529C1 |
| METHOD FOR DIAGNOSTICS OF CHRONIC HEART FAILURE DEVELOPMENT | 2022 |
|
RU2791178C1 |
| METHOD FOR EARLY DIAGNOSIS OF DEVELOPING CHRONIC HEART FAILURE | 2020 |
|
RU2745337C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE WITHIN 12 MONTHS AFTER DECOMPENSATION OF CHRONIC HEART INSUFFICIENCY | 2020 |
|
RU2756391C1 |
| METHOD FOR DIAGNOSING HEPATOCELLULAR CARCINOMA BY DETERMINING COEFFICIENT OF DEVELOPMENT OF HEPATOCELLULAR CARCINOMA BASED ON CHANGES IN T LEVELS OF MICRORNA EXPRESSION IN HUMAN BLOOD PLASMA AND SALIVA | 2020 |
|
RU2760937C1 |
| METHOD FOR PREDICTION OF RISK OF CARDIOVASCULAR MORTALITY IN PATIENTS SUFFERING FROM CHRONIC ISCHEMIC HEART FAILURE COMBINED WITH TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2531947C1 |
| METHOD FOR DIAGNOSING MELANOMA USING EXOSOMAL microRNA | 2020 |
|
RU2769927C2 |
| METHOD FOR DIAGNOSING HEPATIC PATHOLOGIES IN DOGS USING CFA-MIRNAS | 2020 |
|
RU2758950C1 |
| METHOD FOR DIAGNOSING THE DEVELOPMENT OF ISCHEMIC CARDIOMYOPATHY IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2021 |
|
RU2765598C1 |
